TrialHepatology (Baltimore, Md.)2015

Sofosbuvir with peginterferon-ribavirin for 12 weeks in previously treated patients with hepatitis C genotype 2 or 3 and cirrhosis.

Eric Lawitz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.